Question explored with the scientific record
Has anyone apokied for a FOI on the numbers if oeople un kanarjshr beubgbrefused accessed firboots dusgnosus
No FOI request on this exact question appears in the retrieved records.
The evidence block contains 24 studies, none of which is a Freedom of Information request about people being refused access to cancer diagnostic services. The closest match is a 2020 study that used FOI requests to investigate whether NHS organizations took action on inequitable access to biologic drugs for South Asian patients with inflammatory bowel disease [2]. That study found that the organizations denied discrimination, had no routine monitoring, and depended on complaints to act [2]. It is about a different treatment, a different population, and a different access question.
A 2014 study estimated that about 5 in 100 US adults experience a diagnostic error in outpatient care each year, roughly 12 million people, with about half of those errors potentially causing harm [1]. That study did not examine refusals of access, and it did not use FOI requests.
The retrieval cannot answer whether anyone has filed an FOI on this specific question. No record in this set documents such a request, its outcome, or the numbers it would have revealed.
My call: the evidence does not address this question. Confidence: not clear.
Sources used 2
-
The frequency of diagnostic errors in outpatient care: estimations from three large observational studies involving US adult populations
This study synthesizes findings from three large outpatient studies to estimate how often diagnostic errors occur in US adults, finding about 5% (roughly 12 million people per year) with about half potentially causing harm, highlighting a need to measure and reduce outpatient di…
DOI: 10.1136/bmjqs-2013-002627 -
Does the failure to provide equitable access to treatment lead to action by NHS organisations: the case of biologics for South Asians with inflammatory bowel disease?
This study investigates whether inequitable access to biologic therapies for South Asian patients with inflammatory bowel disease in the UK prompts action by NHS organizations, using Freedom of Information requests to map organizational responses and identify monitoring gaps and…
DOI: 10.5750/dlj.v31i1.1751